ATNF stock forecast remains tied to sentiment in the broader genomics market, which has gained 7% month-to-date in 2024 on positive R&D funding news. Things are changing fast in the stock market, but we're staying focused on the future. Worried about the market? We're doubling down on this stock . Following closing of the financing, anticipated on August 1, 2025, the Company plans to rebrand as ETHZilla Corporation. By integrating a pioneering Ethereum Treasury Strategy at closing of the financing, the Company seeks to become a benchmark for onchain treasury management among public companies. ATNF stock forecast technical patterns show a tightening Bollinger Band setup, historically preceding sharp moves in micro-cap biotech names.